Letters to the Editor

Efficacy and safety of canakinumab in familial Mediterranean fever in Japan: a single-centre retrospective study

Y. Tsuji¹, T. Koga², T. Tomokawa³, M. Umeda⁴, N. Iwamoto⁵, A. Kawakami⁶

Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. tkoga@nagasaki-u.ac.jp
Sasebo Chuo Hospital, Rheumatic and Collagen Disease Center, Sasebo, Japan.
Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

CER18074
2024 Vol.42, N°10
PI 2105, PF 2106
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 39404485 [PubMed]

Received: 14/08/2024
Accepted : 09/10/2024
In Press: 15/10/2024
Published: 15/10/2024